^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    OBI-992

    i
    Other names: OBI-992, R992, R-992, OBI992, BSI-992
    Company:
    Biosion, OBI Pharma
    Drug class:
    Topoisomerase I inhibitor, TROP-2-targeted antibody-drug conjugate
    Related drugs:
    6ms
    A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=117, Recruiting, OBI Pharma, Inc
    New P1/2 trial • Metastases
    |
    OBI-992